<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02159001</url>
  </required_header>
  <id_info>
    <org_study_id>22014</org_study_id>
    <nct_id>NCT02159001</nct_id>
  </id_info>
  <brief_title>Electroconvulsive Therapy in Clozapine-resistant Schizophrenia</brief_title>
  <official_title>Efficacy and Cognitive Effects of Electroconvulsive Therapy in Clozapine-Resistant Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Niuvanniemi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Niuvanniemi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Electroconvulsive therapy (ECT) is one of the oldest neuromodulation treatments still used in
      psychiatry. Only case reports and open label non-randomized studies have been published of
      ECT in clozapine-resistant schizophrenia patients. The purpose of this trial is to study the
      efficacy and cognitive effects of add-on ECT treatment (10-course) in schizophrenia patients
      taking clozapine.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive and Negative Symptom Scale</measure>
    <time_frame>2 days</time_frame>
    <description>Positive and Negative Symptom Scale (PANSS) is assessed two days after ECT course</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Schizoaffective Disorder</condition>
  <arm_group>
    <arm_group_label>ECT treatment right after recruitment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group receives electroconvulsive therapy treatment right after they are recruited.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ECT after 4 weeks period.</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group receives electroconvulsive therapy treatment after 4 weeks waiting period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>electroconvulsive therapy</intervention_name>
    <description>10-course, three times a week bilateral frontotemporal ECT</description>
    <arm_group_label>ECT treatment right after recruitment</arm_group_label>
    <arm_group_label>ECT after 4 weeks period.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of schizophrenia or schizoaffective disorder

          -  treatment-resistant to clozapine

          -  age 18 - 64 years

          -  capacity and willingness to give informed consent

        Exclusion Criteria:

          -  serious somatic illness

          -  progressive neurological illness, recent brain damage or sequela of serious brain
             damage

          -  ECT less than 3 months prior to this trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eila Tiihonen, MD, PhD</last_name>
    <phone>+358 295 242 204</phone>
    <email>eila.tiihonen@niuva.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Soile Hyvärinen, MD</last_name>
    <phone>+358 295 242 219</phone>
    <email>soile.hyvarinen@niuva.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Niuvanniemi Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soile Hyvärinen, MD</last_name>
      <phone>+358 295 242 219</phone>
      <email>soile.hyvarinen@niuva.fi</email>
    </contact>
    <investigator>
      <last_name>Soile Hyvärinen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eila Tiihonen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2014</study_first_submitted>
  <study_first_submitted_qc>June 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2014</study_first_posted>
  <last_update_submitted>October 15, 2015</last_update_submitted>
  <last_update_submitted_qc>October 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>clozapine</keyword>
  <keyword>ECT</keyword>
  <keyword>PANSS</keyword>
  <keyword>schizoaffective disorder</keyword>
  <keyword>schizophrenia</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clozapine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

